CA2731941C - Derivatives of enfumafungin as inhibitors of(1,3)-beta.-d-glucan synthase - Google Patents

Derivatives of enfumafungin as inhibitors of(1,3)-beta.-d-glucan synthase Download PDF

Info

Publication number
CA2731941C
CA2731941C CA2731941A CA2731941A CA2731941C CA 2731941 C CA2731941 C CA 2731941C CA 2731941 A CA2731941 A CA 2731941A CA 2731941 A CA2731941 A CA 2731941A CA 2731941 C CA2731941 C CA 2731941C
Authority
CA
Canada
Prior art keywords
pyran
propano
phenanthro
dodecahydro
tetramethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2731941A
Other languages
English (en)
French (fr)
Other versions
CA2731941A1 (en
Inventor
Mark L. Greenlee
Robert Wilkening
James Apgar
Donald Sperbeck
Kenneth James Wildonger
Dongfang Meng
Dann L. Parker
Gregory James Pacofsky
Brian Haid Heasley
Ahmed Mamai
Kingsley Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scynexis Inc
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2731941(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scynexis Inc filed Critical Scynexis Inc
Publication of CA2731941A1 publication Critical patent/CA2731941A1/en
Application granted granted Critical
Publication of CA2731941C publication Critical patent/CA2731941C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2731941A 2008-08-12 2009-08-07 Derivatives of enfumafungin as inhibitors of(1,3)-beta.-d-glucan synthase Active CA2731941C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13610108P 2008-08-12 2008-08-12
US61/136,101 2008-08-12
PCT/US2009/004560 WO2010019204A1 (en) 2008-08-12 2009-08-07 Antifungal agents

Publications (2)

Publication Number Publication Date
CA2731941A1 CA2731941A1 (en) 2010-02-18
CA2731941C true CA2731941C (en) 2016-09-27

Family

ID=41669133

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2731941A Active CA2731941C (en) 2008-08-12 2009-08-07 Derivatives of enfumafungin as inhibitors of(1,3)-beta.-d-glucan synthase

Country Status (7)

Country Link
US (1) US8188085B2 (cg-RX-API-DMAC7.html)
EP (1) EP2326181A4 (cg-RX-API-DMAC7.html)
JP (1) JP5548875B2 (cg-RX-API-DMAC7.html)
CN (2) CN104877001B (cg-RX-API-DMAC7.html)
AU (1) AU2009282474B2 (cg-RX-API-DMAC7.html)
CA (1) CA2731941C (cg-RX-API-DMAC7.html)
WO (1) WO2010019204A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809219A1 (en) 2010-08-26 2012-03-01 Bayer Intellectual Property Gmbh 5-iodo-triazole derivatives
LT3247711T (lt) * 2015-01-19 2022-05-25 Scynexis, Inc. Naujos scy-078 druskos ir polimorfai
EP3609539A1 (en) * 2017-04-10 2020-02-19 Scynexis, Inc. Antifungal agents used in combination
EP4732902A2 (en) 2017-08-04 2026-04-29 Scynexis, Inc. Antifungal agents with enhanced activity in acidic ph
MA51514A (fr) * 2018-01-02 2021-04-07 Scynexis Inc Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes
US12053486B2 (en) 2018-03-09 2024-08-06 Therazure LLC Compositions for the treatment of infections in feet
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques
MA55081A (fr) 2019-02-27 2022-01-05 Scynexis Inc <smallcaps/>? ? ?pneumocystis? ? ? ? ?antifongiques triterpénoïdes pour le traitement ou la prévention de la pneumonie àspp
BR112021022876A2 (pt) 2019-05-16 2022-04-12 Scynexis Inc Método para descolonizar candida auris de uma área anatômica de um sujeito
WO2021092349A1 (en) 2019-11-08 2021-05-14 Scynexis, Inc. Lipid-based formulations of scy-078 salts
EP4058066A4 (en) * 2019-11-15 2023-12-06 The Research Foundation for The State University of New York ANTIFUNGAL COMPOSITIONS AND METHODS OF USE
CN118724779B (zh) * 2024-06-05 2025-09-23 浙江瑞博制药有限公司 一种醛基化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997027860A1 (en) 1996-01-31 1997-08-07 Merck & Co., Inc. Antifungal agent
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
FR2824324B1 (fr) 2001-05-04 2003-08-15 Aventis Pharma Sa Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme medicaments anti-fongiques
CN1705657A (zh) 2002-04-17 2005-12-07 兰贝克赛实验室有限公司 作为抗真菌剂的吡咯衍生物
DK2007396T3 (da) 2006-04-03 2013-03-18 Merck Sharp & Dohme Enfumafungin-derivat som antimykotika

Also Published As

Publication number Publication date
CN104877001B (zh) 2020-07-03
JP5548875B2 (ja) 2014-07-16
CN104877001A (zh) 2015-09-02
US8188085B2 (en) 2012-05-29
CN102176827B (zh) 2015-05-20
CA2731941A1 (en) 2010-02-18
WO2010019204A1 (en) 2010-02-18
US20100113439A1 (en) 2010-05-06
AU2009282474B2 (en) 2014-03-20
EP2326181A1 (en) 2011-06-01
CN102176827A (zh) 2011-09-07
JP2011530593A (ja) 2011-12-22
AU2009282474A1 (en) 2010-02-18
HK1214271A1 (zh) 2016-07-22
EP2326181A4 (en) 2012-11-28

Similar Documents

Publication Publication Date Title
CA2731941C (en) Derivatives of enfumafungin as inhibitors of(1,3)-beta.-d-glucan synthase
CA3021061C (en) Derivatives of amphotericin b
TW200811194A (en) Antifungal agents
AU2021201355B2 (en) Seco macrolide compounds
EP2326172B1 (en) Antifungal agents
AU2009282476B2 (en) Antifungal agents
EP2197447B1 (en) Antifungal agents
HK1214271B (zh) 抗真菌製劑
HK1158017B (en) Antifungal agents

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140718

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 15TH ANNIV.) - STANDARD

Year of fee payment: 15

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240730

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240730

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250723

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250723

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250724

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250724